8-K - Leap Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or othe

Regulation Fd

8.01

Other Events. As disclosed above, on December 30, 2025, the Company issued a press release announcing it has purchased an additional 56,418.09 ZEC, for approxim

Other Event

$29.0M$514.02$334.41

9.01

Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release of the Company, dated December 30, 2025. 104 Cover Page Interactive Data File (emb

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1